Efficacy and safety of LY2963016 insulin glargine versus insulin glargine (Lantus) in Chinese adults with type 2 diabetes: A phase III, randomized, open-label, controlled trial

Feng, WH; Chen, W; Jiang, S; Du, LY; Zhu, DL

Zhu, DL (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Endocrinol, Nanjing 210008, Peoples R China.

DIABETES OBESITY & METABOLISM, 2021; 23 (8): 1786

Abstract

Aim: To compare the efficacy and safety of LY2963016 insulin glargine (LY IGlar) with insulin glargine (Lantus; IGlar) combined with oral antihypergly......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索